Grant: Research Tools and Instruments
University of British Columbia
$100,846.00
Ultracentrifugation system for purification of synthetic biology constructs
FY 2020-21
Summary
Ultracentrifuges are vital pieces of laboratory infrastructure that enable purification and isolation of cellular components based on minute differences in their density. Many of the labs in the School of Biomedical Engineering (SBME) routinely use ultracentrifugation to concentrate and purify nucleic acids, proteins, subcellular components, and viruses. In particular, our labs use ultracentrifugation in purifying gene delivery vehicles, such as plasmids and lentivirus, for mammalian transgenesis of synthetic genetic devices. The recent increase in the number of research labs with genetic engineering and synthetic biology expertise in the SBME has resulted in our need for ultracentrifugation outstripping the capabilities of our existing ultracentrifuge setup. Further, the existing unit is nearing the end of its life and we will be left with no alternative when it fails. Accordingly, we have an urgent need for a new ultracentrifuge to avoid significant and unnecessary delays to our work and degradation of the quality of our research. The requested ultracentrifuge will meet the growing needs of our research groups and the SBME, while providing an opportunity for our HQP to learn how to operate a vital piece of equipment. Since all within SBME will have access to it, this ultracentrifuge will support the research and training of many HQP: approximately 43 HQP have plans to use this ultracentrifuge, including 17 HQP in the labs of the applicants. In addition to numerous other applications, ultracentrifugation is a key step in modern mammalian transgenics, providing our HQP with the opportunity to develop skills in demand for future careers in industry and research. With the growing biotechnology sector in Canada, and gene and cell therapies in particular, the ability to concentrate and purify cellular components is a critical skill for HQP.
Program
Research Tools and Instruments
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RTI-2021-00109
Name nom
de Boer, Carl
Department département
School of Biomedical Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2021
Award amount
100846
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1602
Committee name en
Biological Systems and Functions (RTI)
Committee name fr
Systèmes et fonctions biologiques (OIR)
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1-1
Partie
1
Nb partie
1
Application title
Ultracentrifugation system for purification of synthetic biology constructs
Keyword
NSERC
Application summary
Ultracentrifuges are vital pieces of laboratory infrastructure that enable purification and isolation of cellular components based on minute differences in their density. Many of the labs in the School of Biomedical Engineering (SBME) routinely use ultracentrifugation to concentrate and purify nucleic acids, proteins, subcellular components, and viruses. In particular, our labs use ultracentrifugation in purifying gene delivery vehicles, such as plasmids and lentivirus, for mammalian transgenesis of synthetic genetic devices. The recent increase in the number of research labs with genetic engineering and synthetic biology expertise in the SBME has resulted in our need for ultracentrifugation outstripping the capabilities of our existing ultracentrifuge setup. Further, the existing unit is nearing the end of its life and we will be left with no alternative when it fails. Accordingly, we have an urgent need for a new ultracentrifuge to avoid significant and unnecessary delays to our work and degradation of the quality of our research. The requested ultracentrifuge will meet the growing needs of our research groups and the SBME, while providing an opportunity for our HQP to learn how to operate a vital piece of equipment. Since all within SBME will have access to it, this ultracentrifuge will support the research and training of many HQP: approximately 43 HQP have plans to use this ultracentrifuge, including 17 HQP in the labs of the applicants. In addition to numerous other applications, ultracentrifugation is a key step in modern mammalian transgenics, providing our HQP with the opportunity to develop skills in demand for future careers in industry and research. With the growing biotechnology sector in Canada, and gene and cell therapies in particular, the ability to concentrate and purify cellular components is a critical skill for HQP.